BISOXATIN

Details

Stereochemistry	ACHIRAL
Molecular Formula	C20H15NO4
Molecular Weight	333.3374
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OC1=CC=C(C=C1)C2(OC3=CC=CC=C3NC2=O)C4=CC=C(O)C=C4

InChI

InChIKey=BPKUDUSVDVLOPY-UHFFFAOYSA-N

InChI=1S/C20H15NO4/c22-15-9-5-13(6-10-15)20(14-7-11-16(23)12-8-14)19(24)21-17-3-1-2-4-18(17)25-20/h1-12,22-23H,(H,21,24)

HIDE SMILES / InChI

Molecular Formula	C20H15NO4
Molecular Weight	333.3374
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: http://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/205764/1/ngh033006_1122.pdf
Curator's Comment: description was created based on several sources, including http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE022924&leafletType=leafletFR

Bisoxatin (Laxonalin, Wylaxine) acetate is a stimulant laxative that has been used in the treatment of constipation. The drug showed good effects to habitual constipation and dolichocolon but was not sufficient acting in megacolon. It seems that the drug is effective to constipation due to functional disorders but the effect is not sufficient to constipation caused chiefly by organic colonic changes. No side effect was observed even in long term administration.

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Constipation 112 Sources: http://www.ncbi.nlm.nih.gov/pubmed/4996225/	Primary		Approved 8583	Wylaxine Approved Use Wylaxine is recommended for the treatment of constipation symptoms (non-mechanical origin only) and for preparing a gastrointestinal examination.

PubMed

Title	Date	PubMed
[Colon cleansing by Wylaxine as a preparation for barium enema fluoroscopy (author's transl)].	1974-07-01	4422901
[Treatment of chronic constipation with a contact laxative in pearl form: bisoxatin acetate].	1972	4681351
Treatment of acute and chronic constipation with bisoxatin acetate and bisacodyl. Double-blind crossover study.	1971-06	4996225
A compilation of LD50 values in newborn and adult animals.	1971-01	5542824
Bisoxatin acetate as a postpartum oral laxative: a random double blind controlled experiment in 106 subjects.	1968-01	4865759

Patents

Sample Use Guides

In Vivo Use Guide

120 mg in the evening at bedtime

Route of Administration: Oral

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Wed Apr 02 06:53:07 GMT 2025` Edited by `admin` on `Wed Apr 02 06:53:07 GMT 2025`
Record UNII	7C75N0L7FP
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BISOXATIN

Official Name

English

2,2-BIS(P-HYDROXYPHENYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE

Preferred Name

English

bisoxatin [INN]

Common Name

English

Bisoxatin [WHO-DD]

Common Name

English

Classification Tree Code System Code

WHO-VATC

QA06AB09